Inebilizumab, a first-in-class CD19+ B-cell–targeting agent, is safe and effective for up to 1 year in patients with ...

Administrative layoffs at Connecticut's largest private employer signal stresses on academic medical centers facing federal ...

Scientists have re-created a pain pathway in the brain by growing four key clusters of human nerve cells in a dish. This ...

Attention-deficit/hyperactivity disorder was once thought to be a condition that only affects children, but awareness has grown that it often persists into adulthood. A recent webinar explored how ...

At first I thought the issue was workplaces. But that isn’t it. Employers in fields from finance to advertising, technology to medicine, are deeply concerned for bright, ambitious young people, whose ...

In today’s Health headlines, we’re talking with an infectious diseases doctor for an update on the measles outbreak, what to know about the hantavirus during spring ...

American journalist Megyn Kelly has claimed that she developed an autoimmune disorder after taking two doses of the Pfizer COVID-19 vaccine and a follow-up booster in 2021. "I wish I hadn't done it, ...

A new study has found that delusions typically emerge before hallucinations in individuals at high risk for psychosis, ...

in part using an analysis from Yale School of Medicine Professor Richard Aslin, the NIH awarded $770 million in grants to Connecticut universities in 2023, which UConn said supports 6,609 jobs and ...

Symptoms include flashbacks, hyperarousal, avoidance of trauma-related stimuli, and changes in emotional and cognitive ...

Rutgers-Newark Interim Chancellor Jeffrey Robinson and Virgin Islands President Safiya George are still working out details ...